Xynomic Pharmaceuticals, Inc. is a US incorporated biopharmaceutical company founded by US-China industry veterans and successful entrepreneurs. Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies. Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner. Xynomic Pharma is headquartered in the Shanghai with major operations in US and Shanghai, China.
徐诺药业 Address
3500 South DuPont Highway Dover, DE United States
徐诺药业 Email
Past Companies
Xynomic PharmaChairman, CEO & President
The Trout GroupGeneral Manager, Greater China
Pacific Biopharma Group, Ltd.Co-Founder, CFO and VP